担当　伊奈, 後藤（康）

Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study.

Suzuki Y, Karayama M, Uto T,et al. J Thorac Oncol. 2020;15(8):1317-1327. doi: 10.1016/j.jtho.2020.04.002.

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.

Wu X, Liu X, Zhou Y, et al. Lancet Respir Med. 2021;9(7):747-754. doi: 10.1016/S2213-2600(21)00174-0.

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators, N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2105911.